Clorox (CLX) FY2015 results: revenue $5.7 billion, up 2.6% on the year
Clorox Co. (CLX) reported revenue of $5.7 billion for fiscal 2015, the year ended 30 June 2015, up 2.6% on the year before. Net income was $580 million, up 3.9%, and diluted earnings per share $4.37. The figures are the company's own, from the 10-K it filed with the SEC on 14 August 2018.
Revenue
$5.7 billion
+2.6% on the year
FY2008FY2015
Operating margin
n/a
FY2008FY2015
Net income
$580 million
+3.9% on the year
FY2008FY2015
Diluted EPS
$4.37
+3.3% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
5,655
5,514
5,533
+2.6%
Cost of revenue
3,190
3,158
3,142
+1.0%
Gross profit
2,465
2,360
2,391
+4.4%
Gross margin
43.6%
42.8%
43.2%
Research and development
136
125
130
+8.8%
Selling, general and administrative
798
751
793
+6.3%
Interest expense
100
103
122
-2.9%
Pre-tax income
921
884
n/a
+4.2%
Income tax
315
305
279
+3.3%
Effective tax rate
34.2%
34.5%
n/a
Net income
580
558
572
+3.9%
Net margin
10.3%
10.1%
10.3%
Diluted EPS
$4.37
$4.23
$4.30
+3.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
874
767
775
+14.0%
Capital expenditure
125
137
190
-8.8%
Free cash flow
749
630
585
+18.9%
Free cash flow margin
13.2%
11.4%
10.6%
Cash from investing
-106
-138
-55.0
Cash from financing
-696
-592
-685
Depreciation and amortisation
169
177
182
-4.5%
Share-based compensation
32.0
36.0
35.0
-11.1%
Buybacks
434
260
128
+66.9%
Dividends paid
385
368
335
+4.6%
Dividend per share
$2.99
$2.87
$2.63
+4.2%
Diluted shares, weighted
133m
132m
133m
+0.8%
Shares outstanding at period end
129m
129m
130m
-0.1%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
118
154
146
-23.4%
Debt
2,096
2,313
2,372
-9.4%
Other liabilities
1,940
1,791
1,784
+8.3%
Total liabilities and equity
4,154
4,258
4,302
-2.4%
Fixed assets
918
977
1,021
-6.0%
Goodwill
1,067
1,101
1,105
-3.1%
Intangible assets
585
611
n/a
-4.3%
Cash and equivalents
382
329
299
+16.1%
Receivables
519
546
580
-4.9%
Inventory
385
386
394
-0.3%
Other assets
298
308
903
-3.2%
Total assets
4,154
4,258
4,302
-2.4%
10-K for the year ended 30 June 2015, filed 14 August 2018: the filing.